Optimized BCMA/CS1 bispecific TRuC-T cells secreting IL-7 and CCL21 robustly control multiple myeloma.

MLA

Li, Min, et al. “Optimized BCMA/CS1 Bispecific TRuC-T Cells Secreting IL-7 and CCL21 Robustly Control Multiple Myeloma.” Frontiers in Immunology, vol. 15, Dec. 2024, p. 1502936. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1502936.

APA

Li, M., Zheng, R., Liu, Z., Zhang, P., Zhu, T., Xin, X., Zhao, H., Chen, W., Zheng, B., Zhao, A., & Gao, J. (2024). Optimized BCMA/CS1 bispecific TRuC-T cells secreting IL-7 and CCL21 robustly control multiple myeloma. Frontiers in Immunology, 15, 1502936. https://doi.org/10.3389/fimmu.2024.1502936

Chicago

Li, Min, Rong Zheng, Zairu Liu, Peiyuan Zhang, Tingwei Zhu, Xueyi Xin, Hongli Zhao, et al. 2024. “Optimized BCMA/CS1 Bispecific TRuC-T Cells Secreting IL-7 and CCL21 Robustly Control Multiple Myeloma.” Frontiers in Immunology 15 (December): 1502936. doi:10.3389/fimmu.2024.1502936.